- KR₩118bn
- KR₩80bn
- KR₩165bn
- 83
- 84
- 51
- 86
Annual balance sheet for Cymechs, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48,575 | 62,009 | 31,645 | 59,996 | 52,830 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30,455 | 36,912 | 78,750 | 36,648 | 44,968 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 107,767 | 130,258 | 148,065 | 128,170 | 129,598 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 25,729 | 35,274 | 36,808 | 30,902 | 31,447 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 190,560 | 219,879 | 226,048 | 212,604 | 227,402 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 55,487 | 66,495 | 69,975 | 48,420 | 50,618 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 63,774 | 72,081 | 74,734 | 50,079 | 53,734 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 126,787 | 147,798 | 151,314 | 162,525 | 173,668 |
Total Liabilities & Shareholders' Equity | 190,560 | 219,879 | 226,048 | 212,604 | 227,402 |
Total Common Shares Outstanding |